CN1102335A - Health-care carambola oral liquid - Google Patents

Health-care carambola oral liquid Download PDF

Info

Publication number
CN1102335A
CN1102335A CN 93115371 CN93115371A CN1102335A CN 1102335 A CN1102335 A CN 1102335A CN 93115371 CN93115371 CN 93115371 CN 93115371 A CN93115371 A CN 93115371A CN 1102335 A CN1102335 A CN 1102335A
Authority
CN
China
Prior art keywords
oral liquid
health
carambola
care
consumption
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 93115371
Other languages
Chinese (zh)
Inventor
彭增福
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHENGDU HOSPITAL OF TRADITIONAL CHINESE MEDICINE
Original Assignee
CHENGDU HOSPITAL OF TRADITIONAL CHINESE MEDICINE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHENGDU HOSPITAL OF TRADITIONAL CHINESE MEDICINE filed Critical CHENGDU HOSPITAL OF TRADITIONAL CHINESE MEDICINE
Priority to CN 93115371 priority Critical patent/CN1102335A/en
Publication of CN1102335A publication Critical patent/CN1102335A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The health-care oral liquid is made of carambola (10-20 Wt.%), gynostemma pentaphyllum (15-30), wolfberry fruit (2-5), ginseng (5-10), lucid ganoderma (3-5), champignon (1-5), fleece flower root (5-10), tuckahoe (5-10) and eucommia bark (3-5), and features no toxic by-effect, improving immunity and resisting sanility.

Description

Health-care carambola oral liquid
The present invention is relevant with the natural drug nutrient health, is that the defying age of the main component oral liquid that takes care of health is relevant with Fructus actinidiae chinensis especially.
Domestic traditional anti-senility oral liquid is mainly based on kidney invigorating and YANG supporting, and therapeutic domain mainly is a prostate hyperplasia, prostatitis.To the cardiovascular diseases, men and women's sexual dysfunction has certain regulating action.The oral liquid that the has immunity function that improves.The oral liquid that has more or less contains a certain amount of hormone, and certain side effect is arranged.Anesthesia such as the domestic radiopharmacy that has is with a large amount of synthetic hormones or use ***e, morphine and excited stimulating drug are made health care medicine, use instant effect clinically.Though this quasi drugs can play Dingxing sun effect, and is big to physical impairment, but some medicine life-time service even threat to life.
The purpose of this invention is to provide a kind of nontoxicly, have no side effect, have strengthening the body resistance, eliminating evil, kidney invigorating and YANG supporting improves immune function of human body, activates hemopoietic system, blood pressure lowering, and blood fat reducing improves the efficient natural medicine oral liquid of sex hormone level.
Solvent of the present invention and consumption are as follows: weight %
Fructus actinidiae chinensis 10-20
Herb Gynostemmae Pentaphylli 20-30
Fructus Lycii 5-10
Radix Ginseng 5-10
Ganoderma 5-10
Lentinus Edodes 5-10
Radix Polygoni Multiflori 5-10
Poria 5-10
Cortex Eucommiae 5-10.
The present invention also can have following component and consumption: weight % except having above-mentioned solvent and consumption
Cortex Cinnamomi 3-5
Herba Epimedii 10-20
Rhizoma Alismatis 10-20.
The present invention, screens conventional medicament nature and flavor and function according to the theoretical basis of diseases of aging with reference to name side in ancient times such as Ming Dynasty's " Standards of Diagnosis and Treatment " Fructus Lycii ball.According to the physiological and pathological of modern medicine, pharmacological experiment study and for many years clinical trial result observe, filter out have strengthening the body resistance, eliminating evil, kidney invigorating and YANG supporting, improve immune function of human body, activate hemopoietic system, blood pressure lowering, blood fat reducing improve the medicine of sex hormone level.Preparation technology and quality standard by medicine are processed into the present invention.The present invention has the Chinese medicine speciality, and curative effect is sure, and instant effect has no side effect, and has the function of the one of preventing and treating.Take the present invention for a long time, can improve life efficient and life quality, make the life-span as much as possible near the physiology limit.Can prevent and treat Senile disease, as arteriosclerosis, coronary heart disease, diabetes etc. reduce pathological death.Can reduce the sickness rate of some tumor, and tumor patient is played the auxiliary treatment effect.Can protect hemopoietic system not by radiotherapy, the toxic and side effects of chemotherapy is destroyed, and it is remarkable to improve the immunological function of cancer patients effect.The present invention is used from clinical treatment observation case 160 examples (malignant tumor 60 examples, aching and limp unable headache and dizzy 15 examples of whole body, insomnia and dreamful sleep 15 examples in March, 1986, impotence and premature ejaculation 5 examples, hands and feet coolness lumbago and backache body 15 examples of trembling with fear, hyperlipidemia, diabetes 10 examples, fur is unglazed, yellow hair, poliosis, wrinkle, visual deterioration 10 examples, sexual disorder 5 examples, chronic bronchitis, emphysema 5 examples, alzheimer disease, apoplexy sequela, poor appetite, dyspepsia, sick 5 examples of gastral cavilty, total effective rate 88.94%.
Following is embodiments of the invention:
Embodiment 1:
Component and consumption are as follows: weight %
Fructus actinidiae chinensis 10
Herb Gynostemmae Pentaphylli 30
Fructus Lycii 5
Radix Ginseng 5
Ganoderma 5
Lentinus Edodes 15
The Radix Polygoni Multiflori 10
Poria 10
The Cortex Eucommiae 10
Embodiment 2:
Component of the present invention and consumption are as follows: 1 weight %
Fructus actinidiae chinensis 20
Herb Gynostemmae Pentaphylli 20
Fructus Lycii 10
Radix Ginseng 10
Ganoderma 10
Lentinus Edodes 15
The Radix Polygoni Multiflori 5
Poria 5
The Cortex Eucommiae 5
Embodiment 3:
Fructus actinidiae chinensis 15
Herb Gynostemmae Pentaphylli 25
Fructus Lycii 8
Radix Ginseng 7
Ganoderma 8
Lentinus Edodes 10
The Radix Polygoni Multiflori 7
Poria 10
The Cortex Eucommiae 10
Embodiment 4: component of the present invention and consumption are as follows: weight %
Fructus actinidiae chinensis 10
Herb Gynostemmae Pentaphylli 25
Fructus Lycii 10
Radix Ginseng 10
Ganoderma 8
Lentinus Edodes 12
The Radix Polygoni Multiflori 10
Poria 8
The Cortex Eucommiae 7
Embodiment 5: component of the present invention and consumption are as follows: weight %
Fructus actinidiae chinensis 12
Herb Gynostemmae Pentaphylli 20
Fructus Lycii 5
Radix Ginseng 5
Ganoderma 5
Lentinus Edodes 5
The Radix Polygoni Multiflori 8
Poria 9
The Cortex Eucommiae 8
Cortex Cinnamomi 3
Herba Epimedii 10
Rhizoma Alismatis 10
Embodiment 6: component of the present invention and consumption are as follows: weight %
Fructus actinidiae chinensis 10
Herb Gynostemmae Pentaphylli 20
Fructus Lycii 5
Radix Ginseng 5
Ganoderma 5
Lentinus Edodes 5
The Radix Polygoni Multiflori 5
Poria 5
The Cortex Eucommiae 5
Cortex Cinnamomi 5
Herba Epimedii 15
Rhizoma Alismatis 15
Embodiment 7: component of the present invention and consumption are as follows: weight %
Fructus actinidiae chinensis 10
Herb Gynostemmae Pentaphylli 20
Fructus Lycii 5
Radix Ginseng 5
Ganoderma 5
Lentinus Edodes 5
The Radix Polygoni Multiflori 5
Poria 5
The Cortex Eucommiae 5
Cortex Cinnamomi 5
Herba Epimedii 10
Rhizoma Alismatis 20

Claims (2)

1, health-care carambola oral liquid, its solvent and consumption are as follows: (weight %)
Fructus actinidiae chinensis 10-20
Herb Gynostemmae Pentaphylli 20-30
Fructus Lycii 5-10
Radix Ginseng 5-10
Ganoderma 5-10
Lentinus Edodes 5-10
Radix Polygoni Multiflori 5-10
Poria 5-10
Cortex Eucommiae 5-10
2, health-care carambola oral liquid according to claim 1 also comprises following component and consumption: (weight %)
Cortex Cinnamomi 3-5
Herba Epimedii 10-20
Rhizoma Alismatis 10-20
CN 93115371 1993-11-05 1993-11-05 Health-care carambola oral liquid Pending CN1102335A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 93115371 CN1102335A (en) 1993-11-05 1993-11-05 Health-care carambola oral liquid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 93115371 CN1102335A (en) 1993-11-05 1993-11-05 Health-care carambola oral liquid

Publications (1)

Publication Number Publication Date
CN1102335A true CN1102335A (en) 1995-05-10

Family

ID=4990997

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 93115371 Pending CN1102335A (en) 1993-11-05 1993-11-05 Health-care carambola oral liquid

Country Status (1)

Country Link
CN (1) CN1102335A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1058617C (en) * 1995-10-10 2000-11-22 周明德 Cockscomb beverage
CN102178020A (en) * 2010-12-08 2011-09-14 叶建斌 Formula and preparation method of kiwifruit chewable tablet
CN106718063A (en) * 2016-12-28 2017-05-31 贵州省农作物品种资源研究所 A kind of method of utilization Kiwi berry Pruning Away Branches cultivating ganoderma under Kiwi berry tree shade
CN107853700A (en) * 2017-11-28 2018-03-30 爱可道生物科技有限公司 A kind of globe artichoke liver protection fatigue-resistant drug composition
EP3308768A4 (en) * 2015-06-11 2019-01-16 Celltrion Inc. Cosmetic composition for wrinkle reduction containing gypenoside isolated fromgynostemma pentaphyllum
CN113041281A (en) * 2019-12-27 2021-06-29 湖南湘源美东医药科技有限公司 Flos sophorae immaturus/kiwi fruit and peach seed composition for treating prostatic hyperplasia and preparation thereof

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1058617C (en) * 1995-10-10 2000-11-22 周明德 Cockscomb beverage
CN102178020A (en) * 2010-12-08 2011-09-14 叶建斌 Formula and preparation method of kiwifruit chewable tablet
EP3308768A4 (en) * 2015-06-11 2019-01-16 Celltrion Inc. Cosmetic composition for wrinkle reduction containing gypenoside isolated fromgynostemma pentaphyllum
US11007136B2 (en) 2015-06-11 2021-05-18 Celltrion, Inc. Cosmetic composition for wrinkle reduction containing gypenoside isolated from Gynostemma pentaphyllum
CN106718063A (en) * 2016-12-28 2017-05-31 贵州省农作物品种资源研究所 A kind of method of utilization Kiwi berry Pruning Away Branches cultivating ganoderma under Kiwi berry tree shade
CN107853700A (en) * 2017-11-28 2018-03-30 爱可道生物科技有限公司 A kind of globe artichoke liver protection fatigue-resistant drug composition
CN113041281A (en) * 2019-12-27 2021-06-29 湖南湘源美东医药科技有限公司 Flos sophorae immaturus/kiwi fruit and peach seed composition for treating prostatic hyperplasia and preparation thereof

Similar Documents

Publication Publication Date Title
CN1931301A (en) Chinese medicine prepn for treating mastoproliferation and its prepn process
CN1167638A (en) Liquor for strengthening Yang
CN1297291C (en) Medicine for abstaining from drug addiction and its preparation
CN1102335A (en) Health-care carambola oral liquid
CN1830407A (en) Chinese medicine heat therapy eyeshade and its medicine
CN1698804A (en) Traditional Chinese medicine preparation for treating thoracic obstruction and palpitation and preparation method thereof
CN1060657C (en) Nourishing medicine for preventing and curing toxic and side effect after tumor radiotherapy and chemotherapy and preparation method
CN1883557A (en) Application of 'Guizhi Gancao Longgu Muli' preparation in preparation of medicine for preventing and treating depression
CN1907394A (en) Medicine for treating diabetes foot
CN1136880C (en) Combined Chinese and Western medicine for treating bronchial asthma
CN1173715C (en) Medicine pill for preventing and treating pathological seaility
CN1285354C (en) Medicine for treating cerebral infarction
CN1060332C (en) Compound hypotensive hair-protective liquid and its preparing method
CN1061846C (en) Traditional Chinese medicine prescription for tonifying the kidney reinforcing the spleen and nourishing the blood and preparation process
CN1966008A (en) Medicated wine for treating cancer and tumor and method for preparing same
CN1045892C (en) Chinese medicine Guanxintong for preventing and curing coronary heart disease and angina pectoris, and producing process thereof
CN1158099C (en) Medicine for treating osteoarthritis and its preparing process and application
CN1260973A (en) Health-care tea pillow
CN1903240A (en) Medicinal use of Aralia continentalis kitag
CN1276764C (en) Application of traditional Chinese medicine composition in preparation of medicine for treating iron-deficiency anemia
CN1244340C (en) Chinese medicine for treating coronary heart disease and angina pectoris and its preparing process
CN1263498C (en) Medicine for treating arthraligia caused by wind, cold and wetness evils and with beauty function and its preparing method
CN1269515C (en) A pharmaceutical composition for treating hypertension, externally applied paste and preparation method thereof
CN1051018C (en) Stomach-kidney health-care bag
CN1281252C (en) Medicinal composition for treating urinary lithiasis and its preparing method

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication